4CPS-064 Effectiveness of ribociclib and abemaciclib as first line treatment for metastatic breast cancer in post-menopausal women | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Late breaking abstracts

4CPS-064 Effectiveness of ribociclib and abemaciclib as first line treatment for metastatic breast cancer in post-menopausal women

Free

Online download statistics by month:

Online download statistics by month: May 2023 to November 2024

	Abstract	Full	Pdf
May 2023	213	0	4
Jun 2023	10	0	1
Jul 2023	26	0	5
Aug 2023	30	0	2
Sep 2023	21	0	6
Oct 2023	9	0	2
Nov 2023	22	0	4
Dec 2023	13	0	2
Jan 2024	8	0	0
Feb 2024	12	0	3
Mar 2024	29	0	11
Apr 2024	16	0	1
May 2024	23	0	1
Jun 2024	13	0	0
Jul 2024	6	0	3
Aug 2024	6	0	5
Sep 2024	2	0	3
Oct 2024	11	0	2
Nov 2024	18	0	1
Total	488	0	56